CERS

NASDAQ:CERS

Cerus Corporation

Add to Watchlist
  • Stock

1.30

−1.52%

0.01

USD last updated 13/08 01:59:42

Last Close

1.29

12/08 20:57

Market Cap

345.74M

Beta: 1.03

Volume Today

880.51K

Avg: 1.44M

PE Ratio

−6.88

PFCF: −9.65

OverviewFinancialsAPI

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

    Description

    Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended for transfusion. The company offers...Show More

    Excel Tearsheet

    Earnings

    Earnings per Share (Estimate*)

    -0.15-0.1-0.052019-02-262020-10-292022-05-052024-03-052025-03-04

    Revenue (Estimate*)

    10M20M30M40M50M2019-02-262020-10-292022-05-052024-03-052025-03-04

    *Estimate based on analyst consensus